Ipsen publishes its 2022 half year financial report
Ipsen publishes its 2022 half year financial report
This article or press release has no online content. Please download the associated documents for more information.
Attachment
Ipsen publishes its 2022 half year financial report
- 28 July 2022 - 1 mins read
This article or press release has no online content. Please download the associated documents for more information.
Attachment
Related Press Releases
07 May 2024
5 mins read
Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
06 May 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
24 April 2024
7 mins read
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
22 April 2024
5 mins read
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
17 April 2024
4 mins read
Ipsen publishes its 2023 Universal Registration Document
08 April 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
02 April 2024
7 mins read
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
07 March 2024
1 mins read
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital
15 February 2024
1 mins read
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
13 February 2024
14 mins read